REPORTS

Let’s Pullulate and Expand Your Business

Radiopharmaceuticals Market - Global Professional Analysis and Forecast to 2026

Oct 18, 2019  |  159 PAGES  |  REPORT CODE: CMM216245
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Radiopharmaceuticals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period.

This report presents the market size and development trends by detailing the Radiopharmaceuticals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Radiopharmaceuticals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Radiopharmaceuticals industry and will help you to build a panoramic view of the industrial development.

Radiopharmaceuticals Market, By Type:

  • Diagnostic Radioisotopes

  • Therapeutic Radioisotopes

Radiopharmaceuticals Market, By Application:

  • Oncology

  • Cardiology

  • Other

Some of the leading players are as follows:

  • SIEMENS

  • Mallinckrodt

  • Bracco Imaging

  • Eli Lilly

  • Bayer

  • Jubilant Pharma

  • IBA Group

  • Advanced Accelerator Applications

  • Curium Pharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Radiopharmaceuticals Market: Technology Type Analysis

  • 4.1 Radiopharmaceuticals Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Radiopharmaceuticals Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Diagnostic Radioisotopes

    • 4.3.2 Therapeutic Radioisotopes

5 Radiopharmaceuticals Market: Product Analysis

  • 5.1 Radiopharmaceuticals Product Market Share Analysis, 2018 & 2026

  • 5.2 Radiopharmaceuticals Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Radiopharmaceuticals Market: Application Analysis

  • 6.1 Radiopharmaceuticals Application Market Share Analysis, 2018 & 2026

  • 6.2 Radiopharmaceuticals Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Oncology

    • 6.3.2 Cardiology

    • 6.3.3 Other

7 Radiopharmaceuticals Market: Regional Analysis

  • 7.1 Radiopharmaceuticals Regional Market Share Analysis, 2018 & 2026

  • 7.2 Radiopharmaceuticals Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 SIEMENS

    • 9.1.1 SIEMENS Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Mallinckrodt

    • 9.2.1 Mallinckrodt Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bracco Imaging

    • 9.3.1 Bracco Imaging Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Eli Lilly

    • 9.4.1 Eli Lilly Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Bayer

    • 9.5.1 Bayer Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Jubilant Pharma

    • 9.6.1 Jubilant Pharma Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 IBA Group

    • 9.7.1 IBA Group Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Advanced Accelerator Applications

    • 9.8.1 Advanced Accelerator Applications Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Curium Pharma

    • 9.9.1 Curium Pharma Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

 

The List of Tables and Figures (Totals 79 Figures and 129 Tables)

  • Figure Diagnostic Radioisotopes Radiopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Therapeutic Radioisotopes Radiopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Cardiology market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table North America Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table North America Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table North America Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Canada Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Canada Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Europe Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Europe Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Europe Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Europe Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Germany Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Germany Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table France Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table France Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Italy Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Italy Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Spain Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Spain Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table China Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table China Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Japan Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Japan Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table India Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table India Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table MEA Radiopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table MEA Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table MEA Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table MEA Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Radiopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Radiopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Radiopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table SIEMENS Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bracco Imaging Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jubilant Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table IBA Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Advanced Accelerator Applications Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Curium Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top